http://editor.fresenius-kabi.us/PIs/US-PH-Imipenem-and-Cilastatin-for-Inj-USP-FK-451205C-05-2015-PI.pdf WebSep 4, 2024 · Imipenem / Cilastatin Formulation Version 8.0 Revision Date: 23.08.2024 SDS Number: 15841-00026 Date of last issue: 09.04.2024 Date of first issue: 05.11.2014 7 / 16 Explosive properties : Not explosive Oxidizing properties : The substance or mixture is not classified as oxidizing. Molecular weight : No data available
Primaxin (cilastatin sodium and imipenem) vial label
WebAdditional Names: Cilastatin sodium Molecular Formula: C16H25N2NaO5S Molecular Weight: 380.43 Percent Composition: C 50.51%, H 6.62%, N 7.36%, Na 6.04%, O 21.03%, S 8.43% Properties: Off-white to yellowish-white hygroscopic, amorphous solid. pKa1 2.0; pKa2 4.4; pKa3 9.2. Very sol in water, methanol. pKa: pKa1 2.0; pKa2 4.4; pKa3 9.2 WebFeb 28, 2024 · Cilastatin was administered subcutaneously to rats (GD 6 to 17) and intravenously to rabbits (GD 6 to 18) at doses up to 1000 and 300 mg/kg/day, respectively, approximately 3.2 and 1.9 times the RHD (based on body surface area). ... It is an off-white to yellowish-white, hygroscopic, amorphous compound with a molecular weight of … raymond st jacques cause of death
Primaxin IM (Imipenem and Cilastatin): Uses, Dosage, Side …
Webwhite, nonhygroscopic crystalline compound with a molecular weight of 317.37. It is sparingly soluble in water and slightly soluble in methanol. Its empirical formula is C. 12. H. 17. N. 3. O. 4. S•H. 2. O, and its structural . formula is: Cilastatin sodium is the sodium salt of a derivatized heptenoic acid. Its chemical name is sodium (Z ... WebOct 6, 2024 · It is an off-white to yellowish-white, hygroscopic, amorphous compound with a molecular weight of 380.43. It is very soluble in water and in methanol. Its empirical formula is C 16 H 25 N 2 O 5 SNa, and its structural formula is: Imipenem and Cilastatin for Injection, USP (I.V.) is buffered to provide solutions in the pH range of 6.5 to 8.5. WebJan 12, 2024 · Additionally, body weight loss due to cisplatin was not affected by cilastatin (supplementary Fig. 1C). Figure 1 Administration of cilastatin suppressed cisplatin-induced kidney injury. simplify 83